However, PDL1 expression is often highly heterogeneous within a tumor and often in disagreement between the primary tumor and the metastatic lesions [104–106], which poses a challenge in using the information obtained from analysis of single small biopsy samples in clinical practice. This evidence concerns the gene CD274 and neoplasm.